RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
  Bladder
  Blood
  Bone Cancer
  Brain
  Breast Cancer
  Carcinogens
  Cervical Cancer
  Colon
  Endometrial
  Esophageal
  Gastric Cancer
  Liver Cancer
  Lung
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Skin
  Testicular Cancer
  Therapy
   Pharmacotherapy
   Radiotherapy
   Vaccination
  Thyroid
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Therapy Channel

subscribe to Therapy newsletter
Latest Research : Cancer : Therapy

   EMAIL   |   PRINT
Bionic Nose to Detect Cancers

Mar 31, 2009 - 12:12:47 PM
Shabat's invention is a molecular sensor that acts in a solution. A chemist would add trace amounts of the test material from the field - a spoonful of contaminated drinking water, for example - into the solution and would simply see if the colour of the solution changes. If so, the targeted material - the cancer, explosive or pollutant - is present.

 
[RxPG] Washington, March 31 - Both cancer cells and chemicals used in bombs evade detection because they are present in very small quantities. But now a new method being developed can detect them by amplifying near invisible traces of biomarkers in cancer, materials in explosives or pollutants in water.


Pioneered by Doron Shabat, a bio-organic chemist and professor at Tel Aviv University's School of Chemistry, the technology being developed aims to amplify signals millions and billions of times.

'We are developing a molecular system that amplifies certain events,' said Shabat.

'That way we'll be able to respond faster to medical, security and environmental threats. In effect, our device can amplify just about any chemical system that has a certain kind of reactivity.

'It has the potential to help doctors diagnose diseases - those with biomarkers, and enzymatic activities that are compatible with our molecular probe,' Shabat explained.

'The long list includes a few kinds of cancers, including prostate cancer. But it also has applications for testing for impurities in water. It has both biological and non-biological applications,' he was quoted as saying in a Tel Aviv University release.

Shabat's invention is a molecular sensor that acts in a solution. A chemist would add trace amounts of the test material from the field - a spoonful of contaminated drinking water, for example - into the solution and would simply see if the colour of the solution changes. If so, the targeted material - the cancer, explosive or pollutant - is present.

These findings were published in Chemical Communication.





Advertise in this space for $10 per month. Contact us today.


Related Therapy News
Taccalonolides from bat plants selectively kill cancer cells
Photodynamic therapy can help preserve the voice for patients with early stage laryngeal cancer
Bionic Nose to Detect Cancers
Anti- cancer gene discovered- new strategy for treatment?
Anthracycline induced heart damage can be reduced by prolonging infusion time
Genomic signatures to guide the use of chemotherapeutics
CDK2/FOXO1 as drug target to Prevent Tumors
Telomerase inhibitors may revolutionize cancer therapy
First ever shots of the cervical cancer vaccine administered in Queensland
Gleevec can be toxic to the heart

Subscribe to Therapy Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)